David A Axelrod, Dilek Ince, Meera N Harhay, Roslyn B Mannon, Tarek Alhamad, Matthew Cooper, Michelle A Josephson, Yasar Caliskan, Asif Sharfuddin, Vineeta Kumar, Alexis Guenette, Mark A Schnitzler, Sruthi Ainapurapu, Krista L Lentine
The coronavirus disease 2019 (COVID-19) pandemic has created unprecedented challenges for solid organ transplant programs. While transplant activity has largely recovered, appropriate management of deceased donor candidates who are asymptomatic but have positive nucleic acid test (NAT) for COVID-19 is unclear as this may reflect active infection or prolonged viral shedding. Furthermore, candidates who are unvaccinated or partially vaccinated continue to receive donor offers. In the absence of prospective data, transplant professionals at U...
July 23, 2021: Clinical Transplantation